Citizen Petition from Lauren H. Schwartz, et al.
Details
The document's own metadata, straight from the source system.
- Title
- Citizen Petition from Lauren H. Schwartz, et al.
- Posted
- Dec 23, 2025
- Comment period
- Dec 23, 2025 – ?
- Topics
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Position map
Who stands where on each issue?
Every non-silent position is backed by an excerpt from the comment.
Issues shown
Uncheck an issue to choose another.
| Organization | Access to gender-affirming care | Black box warning for estrogen | Civil liberties and privacy | Hrt informed consent model | Impact on transgender healthcare |
|---|
7 organization-typed comments could not be identified.
Campaigns
Organized form-letter drives, separated from organic one-off comments.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Jul 2, 2026Comment from AnonymousOpposeIndividual
The commenter opposes the citizen petition, characterizing it as a misrepresentation of scientific data and an attempt to penalize transgender women. They argue that estrogen is a standard medication that should be treated as such.
Read comment → - Jun 30, 2026Comment from AnonymousSupportIndividualRead comment →
- Jun 16, 2026Comment from AnonymousOpposeIndividual
The commenter opposes the proposed citizen petition to create a registry of trans women, arguing that it would endanger transgender individuals and violate their privacy and medical autonomy. They contend that gender-affirming care is medically beneficial and that the petition is motivated by prejudice rather than genuine concern.
Read comment → - Jun 11, 2026Comment from Waller AlisiaSupportIndividual
Lauren H. Schwartz expresses support for the petition by highlighting the importance of safe and private access to gender-affirming hormone therapy. She argues against creating barriers to medical care and opposes the idea of placing trans individuals on a registry for prescribed medications.
Read comment → - Jun 10, 2026Comment from M AnnaOpposeIndividual
A cisgender woman opposes the proposed action, arguing that restricting access to hormone replacement therapy (HRT) for transgender individuals violates their right to medical treatment and harms their well-being. She also strongly opposes the creation of a registry for transgender women, citing concerns over privacy violations, harassment, and sexism.
Read comment → - Jun 10, 2026Comment from AnonymousSupportIndividual
Lauren H. Schwartz shares a personal testimonial about how hormone therapy has significantly improved her mental health and quality of life. She supports the action by highlighting the positive impact of access to this care on her personal well-being and ability to function in her community.
Read comment → - Jun 9, 2026Comment from Ross GillianOpposeIndividual
Lauren H. Schwartz, a private citizen, opposes the proposed action because she believes it would lead to the tracking, restriction, and potential harm of transgender individuals. She argues that placing individuals on a list and restricting estrogen prescriptions is dangerous and unlawful.
Read comment → - Jun 9, 2026Comment from AnonymousOpposeIndividualRead comment →
- Jun 8, 2026Comment from AnonymousOpposeIndividual
The commenter opposes the creation of a registry for trans women seeking gender-affirming care, arguing that such a policy is unconstitutional and violates the right to healthcare. They assert that trans women should be treated as women and that the proposed policy lacks scientific and moral justification.
Read comment → - Jun 8, 2026Comment from AnonymousOpposeIndividual
The commenter opposes the citizen petition, arguing that restricting estrogen access based on sex assigned at birth is discriminatory and endangers transgender women. They express concern over the privacy risks of a user registry and advocate for equal access to medicine without surveillance.
Read comment →
